Recent Event

<>

October 17, 2017

Esperion Investor Conference

Speaker: Jane F. Barlow

Real Endpoints LLC

Implications for bempedoic acid?

• Creating and delivering on payer expectations is key

• Payers will welcome an option that is lower cost than PCSK9 inhibitors

• There remains a sizeable number of patients that can’t get to goal with statins and ezetimibe

• Payers’ feedback on the profiles of the combination and bempedoic acid:

‒ On-going cardiovascular outcomes trials – potential limitation

‒ New mechanism of action – positive

‒ LDL-C lowering ability and safety profile – positive

‒ Oral route of administration; less complexity – positive

‒ Combination drug (bempedoic acid + ezetimibe) – positive

view event >

Recent Events

October 22, 2018 - October 25, 2018

Orlando, FL

Attendee: Real Endpoints team

The Academy of Managed Care Pharmacy (AMCP) is the nation’s leading professional association dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health care dollars. Through evidence- and value-based strategies and practices, the Academy’s 8,000 pharmacists, physicians, nurses and other practitioners manage medication therapies for the 270 million Americans served by health plans, pharmacy benefit management firms, emerging care models and government.

view event >

October 1, 2018 - October 2, 2018

Marina del Rey, CA

Speaker: Roger Longman

Real Endpoints LLC

The FH Global Summit is the only conference dedicated to solving global challenges in the care and treatment of familial hypercholesterolemia (FH) through a multi-stakeholder and interdisciplinary approach. An invitation-only event, the summit features a stellar lineup of speakers and panelists who are experts in FH, genomics, precision medicine, alongside leading healthcare practitioners, individuals with FH and industry.

view event >

August 20, 2018 - August 24, 2018

Grand Hyatt, Washington, DC

Speaker: Roger Longman

Real Endpoints LLC

Cambridge Healthtech Institute’s Seventh Annual, Coverage and Reimbursement for Advanced Diagnostics – Latest Developments in the Dx Reimbursement Landscape. Ammar Qadan, Vice President, Global Market Access, Illumina and Roger Longman, CEO, RealEndpoints present: Addressing the Biggest Commercial Problem in Diagnostics

view event >

July 24, 2018 - July 25, 2018

Baltimore, MD

Panelist: Jane F. Barlow, MD, MPH, MBA

Real Endpoints LLC

To explore new models of payment and benefit designs for high-investment medications, the AMCP convened a stakeholder conference in Baltimore Maryland on July 24 and 25, 2018. Health care leaders representing health plans, integrated delivery systems, pharmacy benefit managers, employers, national professional associations, the federal government, and biopharmaceutical companies participated in the forum.

view event >

May 19, 2018 - May 23, 2018

Baltimore, MD

Attendee: Real Endpoints team

ISPOR is the leading global scientific and educational organization for health economics and outcomes research (HEOR) and its use in decision making to improve health. Our annual conference includes over 5,000 attendess from across the industry.

view event >

May 17, 2018 12:00pm ET

Roger Longman
Jane Barlow, MD

Real Endpoints LLC

We’ve seen an explosion of value-based deals: from 10 in 2015-2016 to 25 from 2017 to Q1 2018 (and we’re on pace for 30+ this year), according to the Real Endpoints database. But we’ve also had the time to see which deals from 2015-16 haven’t worked — and why. We will take a candid look at what’s worked and what hasn’t worked in value-based agreements — as well as preview the drugs coming to market in 2018 that could benefit from value-based agreements.

view event >